OICR News / Tag

Martin Yaffe

Browse news tagged Martin Yaffe.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

CollaborationBreast cancer

Massive international clinical trial aims to answer a pivotal question in breast cancer screening

TMIST, co-led by Canadian researchers, is working to determine whether a newer form of breast imaging can better detect aggressive breast cancers. The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is one of the largest breast…

ArticleJun 02, 2026

TechnologyDiagnosis

How AI can help diagnose cancers that are otherwise hard to spot

OICR-supported researchers are harnessing the power of artificial intelligence to help diagnose cancer quickly and accurately. The difference between cancerous and non-cancerous tissue can be so subtle it’s almost imperceptible. And yet distinguishing one from…

ArticleMar 06, 2024

TechnologyBreast cancer

Research suggests expansion of Ontario breast cancer screening program will save lives

Dr. Martin Yaffe talks about the evidence for starting regular mammograms at age 40 instead of 50. Thousands more Ontarians can now access publicly funded mammograms, and experts say the move will save many lives…

ArticleNov 16, 2023

TalentBreast cancer

Mammography innovator changing how we see cancer

Dr. Martin Yaffe’s research on imaging technologies has helped make breast cancer screening more accurate and improve outcomes for women affected by the disease. Over nearly half a century researching medical imaging, Dr. Martin Yaffe…

ArticleMar 30, 2022

TechnologyBreast cancer

New retrospective study aims to identify mutations to better diagnose breast cancer in the future

Toronto (August 17, 2016) – Mr. Peter Goodhand, President of The Ontario Institute for Cancer Research (OICR), today announced a new collaborative research study in partnership with Thermo Fisher Scientific and Queen’s University to help…

ArticleAug 17, 2016

CommercializationBreast cancer

Technology developed with OICR funding receives $4 million in support from NCI

In 2006 Dr. Martin Yaffe's lab at Sunnybrook Research Institute developed a new way of preparing whole-mount sections of breast tissue, which opened up the exciting possibility of correlating pathology directly with medical imaging. However,…

ArticleApr 29, 2016

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Martin Yaffe

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Massive international clinical trial aims to answer a pivotal question in breast cancer screening

How AI can help diagnose cancers that are otherwise hard to spot

Research suggests expansion of Ontario breast cancer screening program will save lives

Cancer solved together — in your inbox

Mammography innovator changing how we see cancer

New retrospective study aims to identify mutations to better diagnose breast cancer in the future

Technology developed with OICR funding receives $4 million in support from NCI